SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001894562-24-000018
Filing Date
2024-03-04
Accepted
2024-03-04 21:20:21
Documents
1
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1709605211.html 4  
1 FORM 4 wk-form4_1709605211.xml 4 3866
  Complete submission text file 0001894562-24-000018.txt   5284
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
Marrazzo Jeffrey D (Reporting) CIK: 0001631262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 24717989

Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)